Incidental Mutation 'R9026:Lyve1'
ID 686736
Institutional Source Beutler Lab
Gene Symbol Lyve1
Ensembl Gene ENSMUSG00000030787
Gene Name lymphatic vessel endothelial hyaluronan receptor 1
Synonyms lymphatic vessel endothelial HA receptor-1, Xlkd1, 1200012G08Rik, Lyve-1
MMRRC Submission 068855-MU
Accession Numbers
Essential gene? Probably non essential (E-score: 0.059) question?
Stock # R9026 (G1)
Quality Score 225.009
Status Validated
Chromosome 7
Chromosomal Location 110449814-110462160 bp(-) (GRCm39)
Type of Mutation missense
DNA Base Change (assembly) C to A at 110453182 bp (GRCm39)
Zygosity Heterozygous
Amino Acid Change Cysteine to Phenylalanine at position 138 (C138F)
Ref Sequence ENSEMBL: ENSMUSP00000033050 (fasta)
Gene Model predicted gene model for transcript(s): [ENSMUST00000033050]
AlphaFold Q8BHC0
Predicted Effect probably damaging
Transcript: ENSMUST00000033050
AA Change: C138F

PolyPhen 2 Score 1.000 (Sensitivity: 0.00; Specificity: 1.00)
SMART Domains Protein: ENSMUSP00000033050
Gene: ENSMUSG00000030787
AA Change: C138F

DomainStartEndE-ValueType
signal peptide 1 23 N/A INTRINSIC
LINK 37 129 2.49e-27 SMART
low complexity region 160 173 N/A INTRINSIC
transmembrane domain 232 254 N/A INTRINSIC
Coding Region Coverage
  • 1x: 100.0%
  • 3x: 99.9%
  • 10x: 99.7%
  • 20x: 99.2%
Validation Efficiency 100% (81/81)
MGI Phenotype FUNCTION: [Summary is not available for the mouse gene. This summary is for the human ortholog.] This gene encodes a type I integral membrane glycoprotein. The encoded protein acts as a receptor and binds to both soluble and immobilized hyaluronan. This protein may function in lymphatic hyaluronan transport and have a role in tumor metastasis. [provided by RefSeq, Jul 2008]
PHENOTYPE: Mice homozygous for one allele display enlarged lymphatic vessels and increased interstitial-lymphatic flow. However, mice homozygous for a second allele do not display any abnormalities in the lymphatic system. [provided by MGI curators]
Allele List at MGI
Other mutations in this stock
Total: 81 list
GeneRefVarChr/LocMutationPredicted EffectZygosity
1110002E22Rik C A 3: 137,770,909 (GRCm39) Q33K possibly damaging Het
Acap2 A G 16: 30,925,906 (GRCm39) L550P probably damaging Het
Acsm3 A T 7: 119,373,845 (GRCm39) S244C probably benign Het
Adam28 T A 14: 68,846,593 (GRCm39) D740V probably benign Het
Adcy4 C A 14: 56,016,426 (GRCm39) V342L probably damaging Het
Adcyap1r1 A G 6: 55,458,107 (GRCm39) T303A probably benign Het
Agr2 T C 12: 36,046,091 (GRCm39) V74A probably benign Het
Akp3 A T 1: 87,054,786 (GRCm39) T374S possibly damaging Het
Ankrd36 A T 11: 5,610,696 (GRCm39) I1181L probably benign Het
Arhgap11a A T 2: 113,664,411 (GRCm39) V624E probably benign Het
Arhgap30 A T 1: 171,228,258 (GRCm39) D112V probably damaging Het
Atp8b4 A G 2: 126,184,883 (GRCm39) F927L probably benign Het
Bend4 C A 5: 67,584,475 (GRCm39) G150C unknown Het
Cd300lg T A 11: 101,944,998 (GRCm39) S403T probably damaging Het
Cep57l1 T A 10: 41,607,086 (GRCm39) Q159L probably damaging Het
Cipc C T 12: 86,999,634 (GRCm39) T57M probably damaging Het
Def8 T C 8: 124,186,391 (GRCm39) C377R probably damaging Het
Dock1 A G 7: 134,720,746 (GRCm39) D1285G probably damaging Het
Efcab10 A G 12: 33,448,398 (GRCm39) D77G probably damaging Het
Eml4 C T 17: 83,764,479 (GRCm39) T663M probably damaging Het
Ercc8 A G 13: 108,320,389 (GRCm39) E325G possibly damaging Het
Ermap C A 4: 119,035,240 (GRCm39) A583S probably damaging Het
F13a1 C T 13: 37,102,506 (GRCm39) G406S probably null Het
Faap20 T A 4: 155,335,426 (GRCm39) C141S probably benign Het
Fam193a A G 5: 34,616,536 (GRCm39) T904A possibly damaging Het
Garin2 T C 12: 78,757,097 (GRCm39) F18S probably benign Het
Gas8 A G 8: 124,260,134 (GRCm39) D455G probably benign Het
Gm21863 T C 12: 20,004,521 (GRCm39) S6P probably damaging Het
Gm4841 A T 18: 60,403,988 (GRCm39) I35N probably damaging Het
Grk4 T A 5: 34,877,084 (GRCm39) C260S probably damaging Het
Huwe1 G A X: 150,716,084 (GRCm39) R4331Q unknown Het
Ighv5-6 A G 12: 113,589,247 (GRCm39) Y78H probably benign Het
Itpr3 G A 17: 27,337,651 (GRCm39) probably benign Het
Kl T A 5: 150,876,491 (GRCm39) S104T probably benign Het
Med27 G A 2: 29,399,446 (GRCm39) W92* probably null Het
Mical3 A T 6: 120,986,848 (GRCm39) probably benign Het
Mrgpra4 C A 7: 47,631,208 (GRCm39) R131L possibly damaging Het
Myf5 T C 10: 107,321,308 (GRCm39) N162S probably benign Het
Myh15 G A 16: 49,007,433 (GRCm39) E1835K probably damaging Het
Myo9a T A 9: 59,716,757 (GRCm39) Y486N probably damaging Het
Ncapg T A 5: 45,853,115 (GRCm39) N860K probably benign Het
Nr4a3 T C 4: 48,052,194 (GRCm39) F316S possibly damaging Het
Nsd3 T A 8: 26,172,576 (GRCm39) S778R probably benign Het
Or2r2 A G 6: 42,463,795 (GRCm39) F111L probably damaging Het
Or4c119 A T 2: 88,986,988 (GRCm39) V177E probably benign Het
Or4c31 A G 2: 88,292,196 (GRCm39) I190V probably damaging Het
Or5p6 A G 7: 107,631,286 (GRCm39) F88S probably damaging Het
Or7e173 T C 9: 19,938,344 (GRCm39) N297D Het
Or8b37 T A 9: 37,958,885 (GRCm39) Y122* probably null Het
Or8w1 A T 2: 87,465,369 (GRCm39) C241S probably damaging Het
Or9m2 A G 2: 87,820,568 (GRCm39) T38A probably damaging Het
Pdlim4 C T 11: 53,946,280 (GRCm39) G231S probably benign Het
Pknox2 C T 9: 36,821,044 (GRCm39) V273I possibly damaging Het
Pm20d1 A G 1: 131,739,822 (GRCm39) H390R probably benign Het
Prkg2 A T 5: 99,114,386 (GRCm39) D587E probably benign Het
Prps1l1 T A 12: 35,035,546 (GRCm39) D220E possibly damaging Het
Prss3l A G 6: 41,422,990 (GRCm39) F4L probably benign Het
Ptchd3 T C 11: 121,721,682 (GRCm39) V185A possibly damaging Het
Rag2 A T 2: 101,460,494 (GRCm39) N268I possibly damaging Het
Rarres2 A G 6: 48,549,020 (GRCm39) probably null Het
Rrp12 T C 19: 41,860,223 (GRCm39) H1000R probably benign Het
S100a2 A T 3: 90,498,811 (GRCm39) Y104F unknown Het
Sell A G 1: 163,893,042 (GRCm39) Y86C probably damaging Het
Serpinb6d A T 13: 33,851,656 (GRCm39) T138S possibly damaging Het
Slamf7 T A 1: 171,466,312 (GRCm39) I228F probably benign Het
Slc11a1 G A 1: 74,416,325 (GRCm39) V92M probably damaging Het
Spi1 A G 2: 90,912,862 (GRCm39) N5S unknown Het
Stard9 G T 2: 120,536,283 (GRCm39) D4151Y probably damaging Het
Stmnd1 A G 13: 46,452,983 (GRCm39) T220A probably benign Het
Tacc2 G T 7: 130,225,266 (GRCm39) W650C probably damaging Het
Tmc5 A G 7: 118,241,594 (GRCm39) N429S possibly damaging Het
Tmem201 A C 4: 149,812,627 (GRCm39) L230V probably benign Het
Tmem222 T C 4: 132,997,119 (GRCm39) E94G possibly damaging Het
Trappc4 A G 9: 44,315,655 (GRCm39) F186S probably damaging Het
Trim17 A G 11: 58,862,273 (GRCm39) N435S probably benign Het
Trim68 A T 7: 102,329,447 (GRCm39) L227Q probably damaging Het
Tuba3b T G 6: 145,563,996 (GRCm39) V14G possibly damaging Het
Ubr2 G T 17: 47,245,041 (GRCm39) H1662N probably damaging Het
Vps13c T A 9: 67,861,863 (GRCm39) V2915E probably damaging Het
Vsig10 C T 5: 117,476,323 (GRCm39) T259I probably benign Het
Zfp267 A G 3: 36,219,066 (GRCm39) Y363C possibly damaging Het
Other mutations in Lyve1
AlleleSourceChrCoordTypePredicted EffectPPH Score
R0465:Lyve1 UTSW 7 110,452,034 (GRCm39) critical splice donor site probably null
R1600:Lyve1 UTSW 7 110,452,902 (GRCm39) critical splice donor site probably null
R4553:Lyve1 UTSW 7 110,451,567 (GRCm39) critical splice acceptor site probably null
R8036:Lyve1 UTSW 7 110,458,649 (GRCm39) missense probably damaging 1.00
R8809:Lyve1 UTSW 7 110,452,999 (GRCm39) missense probably damaging 1.00
Predicted Primers PCR Primer
(F):5'- TTGTCTTCCGTGCCATGGAG -3'
(R):5'- AAGCCTGAGCATTTGAGTCG -3'

Sequencing Primer
(F):5'- TCCGTGCCATGGAGGTCAAAG -3'
(R):5'- TCACAGAAGGCCTCATTGG -3'
Posted On 2021-11-19